Presently, Colin Bond is Non-Executive Chairman at European ScreeningPort GmbH and Chief Financial Officer of Vifor Pharma AG, Chief Financial Officer for Vifor Pharma Management AG (a subsidiary of Vifor Pharma AG). He is also on the board of Siegfried Holding AG, Vifor Fresenius Medical Care Renal Pharma Ltd. and BioPharma Credit PLC and Member of Royal Pharmaceutical Society of Great Britain.
Colin Bond previously occupied the position of Chief Financial Officer of Evotec SE, Chief Financial Officer of Great Lakes Chemical Corp., Chief Financial Officer for Novelis AG, Chief Financial Officer at Novelis Europe Holdings Ltd., Chief Financial Officer at Jet Aviation Management AG, Chief Financial Officer for Ecolab (Schweiz) GmbH, Auditor of PricewaterhouseCoopers LLP, Auditor for Arthur Andersen AG and Auditor of Procter & Gamble AG.
Colin Bond received an MBA from London Business School and an undergraduate degree from the University of Aston.
View full profile
Linked companies |
---|
European ScreeningPort GmbH
|
Chairman
|
Vifor Pharma Management AG
Vifor Pharma Management AG Pharmaceuticals: MajorHealth Technology Vifor Pharma Management AG develops and manufactures pharmaceuticals products for the treatment of iron deficiency. It also offers a diversified portfolio of prescription medicines as well as over-the-counter products. The company operates in the following key business areas: iron deficiency with and without anemia, kidney disease, infectious diseases/OTX products and consumer healthcare, with a focus on non-prescription products. Vifor Pharma Management was founded by Caspar Friedrich Hausmann in 1872 and is headquartered in Glattbrugg, Switzerland. |
Director of Finance/CFO
|